Current first-line pharmacotherapies for TS, such as aripiprazole, haloperidol, risperidone, and tiapride, primarily exert their therapeutic effects through antagonism or partial agonism of the dopamine D2 receptor (35). Here, DRD2 is linked to Timothy syndrome.